Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleLaboratory Studies

Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy

Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou and Gerhard van Kaick
Journal of Nuclear Medicine November 1992, 33 (11) 1981-1987;
Uwe Haberkorn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Reinhardt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludwig G. Strauss
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franz Oberdorfer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin R. Berger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette Altmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reinhard Wallich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonia Dimitrakopoulou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard van Kaick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 33, Issue 11
November 1, 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy
Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou, Gerhard van Kaick
Journal of Nuclear Medicine Nov 1992, 33 (11) 1981-1987;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy
Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou, Gerhard van Kaick
Journal of Nuclear Medicine Nov 1992, 33 (11) 1981-1987;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Treatment of Breast Tumor Cells In Vitro with the Mitochondrial Membrane Potential Dissipater Valinomycin Increases 18F-FDG Incorporation
  • Assessment of Treatment Response by Autoradiography with 14C-Aminocyclopentane Carboxylic Acid, 67Ga-DTPA, and 18F-FDG in a Herpes Simplex Virus Thymidine Kinase/Ganciclovir Brain Tumor Model
  • 2-[18F]Fluoro-2-deoxyglucose and Glucose Uptake in Malignant Gliomas before and after Radiotherapy: Correlation with Outcome
  • Google Scholar

More in this TOC Section

  • Potassium and Thallium Uptake in Dog Myocardium
  • Kinetics of Technetium-99m-Teboroxime in Reperfused Nonviable Myocardium
  • Assessment of Cancer Recurrence in Residual Tumors after Fractionated Radiotherapy: A Comparison of Fluorodeoxyglucose, L-Methionine and Thymidine
Show more Laboratory Studies

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire